97 related articles for article (PubMed ID: 7473468)
21. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
23. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
[TBL] [Abstract][Full Text] [Related]
24. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
25. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
26. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
[TBL] [Abstract][Full Text] [Related]
27. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
Fries JF; Bruce B
J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
[TBL] [Abstract][Full Text] [Related]
28. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C
Gastroenterology; 2003 Feb; 124(2):288-92. PubMed ID: 12557133
[TBL] [Abstract][Full Text] [Related]
29. Identification of patients at risk for gastropathy associated with NSAID use.
Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
J Rheumatol Suppl; 1990 Feb; 20():12-9. PubMed ID: 2325051
[TBL] [Abstract][Full Text] [Related]
30. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
31. Population-based mortality outcome of rheumatoid arthritis in females.
Iacovino JR
J Insur Med; 2002; 34(2):86-8. PubMed ID: 15305782
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
33. The risk of hospitalized infection in patients with rheumatoid arthritis.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
J Rheumatol; 2008 Mar; 35(3):387-93. PubMed ID: 18260176
[TBL] [Abstract][Full Text] [Related]
34. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
Cibere J; Sibley JT; Haga M
J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
[TBL] [Abstract][Full Text] [Related]
35. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
37. Patterns of drug use in rheumatoid arthritis.
Bérard A; Solomon DH; Avorn J
J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
[TBL] [Abstract][Full Text] [Related]
38. The importance of gastrointestinal (GI) symptom severity in rheumatoid and osteoarthritis: symptom rates and risk for GI hospitalization.
Wolfe F
J Rheumatol; 2000 Jul; 27(7):1661-7. PubMed ID: 10914848
[TBL] [Abstract][Full Text] [Related]
39. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
[TBL] [Abstract][Full Text] [Related]
40. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
Van Doornum S; Brand C; King B; Sundararajan V
Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
